Keywords: wyeth, conbriza, approved, europe, drugmaker, bazedoxifene, been

Wyeth's Conbriza approved in Europe

Article | 28 April 2009

Print This

US drugmaker Wyeth's Conbriza (bazedoxifene) has been approved as a treatment of post-menopausal osteoporosis in women at increased risk of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in